European Union International Standa... NGOs United Nations
Afghanistan Bangladesh Bhutan British Indian Ocean... Brunei Burma (Myanmar) Cambodia China Christmas Island Cocos (Keeling) Islands East Timor Hong Kong India Indonesia Japan Kyrgyzstan Laos Macao Malaysia Maldives Mongolia Nepal North Korea Pakistan Philippines Singapore South Korea Sri Lanka Taiwan (Republic of ... Tajikistan Thailand Turkmenistan Uzbekistan Vietnam
|
GuadeloupeConsumer Product Safety Commission (CPSC)
Report Title: |
CPSC Nanomaterial Statement |
Report ID: |
193 |
Date: |
1/1/2005 |
Author: |
Consumer Product Safety Commission (CPSC) |
Report Type: |
Statement |
URL: |
[cpscnanostatement.pdf] |
Country: |
United States of America |
Organization: |
Consumer Product Safety Commission (CPSC) |
Summary: |
The US Consumer Product Safety Commission (CPSC) released this brief statement regarding the safety of nanomaterial-containing products. Pre-market registration is not required, and the CPSC cannot evaluate public risk until a product is introduced for sale. Because there are no nanotechnology-specific regulations, the CPSC will examine nanotech products using the same criteria applied to all other consumer products, checking for defects causing substantial risk of injury to the public. Responsibility is on manufacturers to ensure that their products are safe, and any information to the contrary must be reported to the CPSC. Chronic health effects, a larger concern of nanomaterials, are examined in a similar fashion. The CPSCs chronic hazard guidelines, in conjunction with the Federal Hazardous Substances Act (FHSA), are used in determining whether a product has the potential to cause substantial personal injury or substantial illness. At present, the CPSC is reviewing and updating its guidelines to address the usage of nanomaterials in consumer products. |
Archived Copy: |
CPSCNanostatement_193_6364.pdf |
 |
|
|